
Meanwhile, federal enforcement actions over improper patient assistance continue to arise
Meanwhile, federal enforcement actions over improper patient assistance continue to arise
Your serialization systems aren’t as interoperable as you might think
Investigative journalist Katherine Eban returns with an indictment of generic drug quality
FDA-accepted pilot projects hope to demonstrate how industry compliance could be realized by the 2023 deadline
A complement to the classic randomized clinical trial may benefit drug commercialization
Contract logistics provider will have 30 facilities by the end of this year
Kalderos garners $7-million Series A funding from Mercato Partners
New science breakthroughs, and easy access to financing, propel this year’s M&A and licensing market
Will retain position until May 2020
Latest acquisition brings commercial assets from Mission Pharmacal
Association will promote its members' value to the public via digital advertising and publishing
Business opportunities expand, include selling healthcare data to researchers
Managed Retail Network will offer “light” patient support services through 25,000 pharmacies
$21-million expansion of Pennsylvania facilities
Mobile apps promise to expand hub support for specialty pharmaceuticals
Rochester Drug Cooperative’s former CEO, Laurence Doud, is arrested
10th edition of the Biopharma Cold Chain Sourcebook predicts above-average growth
Counterfeit Xanax (alprazolam), plus meth and other controlled substances, were sold on the dark web
The Unstoppable Growth of Prescription Drug Prices
Combining sublingual nitroglycerin and aspirin in a tablet or other embodiments could be a significant global market opportunity
Lawsuit to recover $221,000 in losses filed against Agility Logistics, Hapag-Lloyd and the port
A final rule is still in the works at HHS, but some manufacturers are testing the inclusion of prices in TV ads
It takes gritty work to make an AI application succeed—but it can be worth the effort
Schreiner MediPharm and Edelmann Group develop a demo version
The Big Three, plus Rochester Drug, face civil penalties over opioid distribution